SIRPA and breast carcinoma: Silencing of CD47 and SIRP-a promote breast cancer cells death by PMA-differentiated THP-1 cells (5), and radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer (6).